| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/17/2008 | CA2391076C Solutions containing epinastin |
| 06/17/2008 | CA2369947C Hydroxamic acid derivative |
| 06/17/2008 | CA2331737C Agents for relieving side effects caused by use of an anti-tumour agent |
| 06/17/2008 | CA2309202C Adenosine a1 receptor agonists |
| 06/17/2008 | CA2281562C Forskolin for promoting lean body mass |
| 06/17/2008 | CA2272291C Crf antagonistic quino- and quinazolines |
| 06/17/2008 | CA2264118C Tetrahydroquinoline derivatives as eaa antagonists |
| 06/17/2008 | CA2261762C Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/17/2008 | CA2253113C Carbohydrate derivatives |
| 06/17/2008 | CA2249446C Irreversible inhibitors of tyrosine kinases |
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2202487C Fused pyrrolocarbazoles |
| 06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2163361C Therapeutic substituted guanidines |
| 06/12/2008 | WO2008070783A2 Compositions and methods comprising zingiber species |
| 06/12/2008 | WO2008070552A2 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 06/12/2008 | WO2008069972A2 Systems for effecting cessation of tobacco use |
| 06/12/2008 | WO2008069970A2 Nicotine formulations, kits and systems and methods for their use |
| 06/12/2008 | WO2008069652A1 Combinations of a sphingolipid and an hmg-coa reductase inhibitor for treating hypercholesterolemia |
| 06/12/2008 | WO2008069276A1 Cancer therapeutic agent and anti-carcinogenic agent |
| 06/12/2008 | WO2008069242A1 Novel bicyclic heterocyclic compound |
| 06/12/2008 | WO2008069168A1 Method for production of 2-hydroxymethylpyrrolidin-3,4-diol or intermediate thereof |
| 06/12/2008 | WO2008069102A1 Prophylactic/therapeutic agent for inflammatory bowel disease |
| 06/12/2008 | WO2007089548A3 Compounds and methods for modulating protein trafficking |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139666 Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues |
| 06/12/2008 | US20080139659 Reducing intracranial pressure with sulfonylurea receptor 1 antagonist |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139597 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 06/12/2008 | US20080139583 Phosphodiesterase 4 inhibitors |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139553 Spiro-piperidine derivatives |
| 06/12/2008 | US20080139524 Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139515 Stable amifostine liquid concentrate |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139498 Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof |
| 06/12/2008 | US20080139493 delivery of various cargo moieties into cells; more amenable than peptide "protein transduction domains" due to their ease of preparation and in vivo stability by virtue of their resistance to cellular enzymes that degrade peptides |
| 06/12/2008 | US20080139491 Method For Investigating Cytosine Methylation in Dna Sequences By Means of Triplex-Forming Oligomers |
| 06/12/2008 | US20080139473 Preventing or reducing cerebral ischemia and/or reperfusion injury from surgical operations; utilizing kunitz domain polypeptides |
| 06/12/2008 | US20080139472 Preventing and/or restoring cognitive dysfunction in fragile X syndrome; AMPA potentiation |
| 06/12/2008 | US20080139464 Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof |
| 06/12/2008 | US20080139460 Binding agents for CD44 glycoproteins and methods of use |
| 06/12/2008 | US20080139459 Conjugates A Polypeptide And A Pentasaccharide |
| 06/12/2008 | US20080139452 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders |
| 06/12/2008 | US20080139449 X-Ray Structure of Human Fpps and Use For Selecting Fpps Binding Compounds |
| 06/12/2008 | US20080138452 Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs |
| 06/12/2008 | US20080138426 Remedies for sex hormone dependent disease |
| 06/12/2008 | US20080138416 Method and systems for using biopolymer-based beads and hydrogels |
| 06/12/2008 | US20080138415 Composition and method for producing composition for constructing tissue, and tissue construct |
| 06/12/2008 | US20080138406 Composition for treatment of pain in bones and joints |
| 06/12/2008 | US20080138399 Dual release nicotine formulations, and systems and methods for their use |
| 06/12/2008 | US20080138398 Dual release nicotine formulations, and systems and methods for their use |
| 06/12/2008 | US20080138393 Water soluble extract of spinach for prevention and repair of DNA damage |
| 06/12/2008 | US20080138389 Contains a solvent-free matrix layer containing (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol; increased solubility |
| 06/12/2008 | US20080138388 Contains a basic drug (donepezil) having an octanol/water partition coefficient in the free state of 3 or above, a pressure-sensitive adhesive base and a methacrylic acid and methyl methacrylate |
| 06/12/2008 | US20080138384 Oral hair growth stimulants comprising orthosiphon |
| 06/12/2008 | US20080138375 Macrocyclic lactone compounds and methods for their use |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138346 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/12/2008 | US20080138339 Anti human ovarian cancer-anti CD3 bispecific antibody |
| 06/12/2008 | US20080138337 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 06/12/2008 | US20080138323 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 06/12/2008 | US20080138321 Method for enhancing stem cell trafficking |
| 06/12/2008 | CA2670491A1 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930340A1 Antiproliferative activity of G-rich oligonucleotides and method of using the same to bind to nucleolin |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1930027A2 A composition of sodium channel blocking compound |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1928807A2 Oncogenic regulatory rnas for diagnostics and therapeutics |
| 06/11/2008 | EP1928594A2 Method for production of single- and multi-layer microcapsules |
| 06/11/2008 | EP1928457A2 Quinolines and their therapeutic use |
| 06/11/2008 | EP1928454A2 Pyridone derivatives for modulating stress-activated protein kinase system |
| 06/11/2008 | EP1928443A1 2-aminoalcohols for the treatment of neurodegenerative diseases |
| 06/11/2008 | EP1928442A2 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof |
| 06/11/2008 | EP1751183A4 Fas associated factor 1 |
| 06/11/2008 | EP1737435A4 Fluid composition used to simulate human synovial fluid |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1492803B1 New analogs of nitrobenzylthioinosine |
| 06/11/2008 | EP1480984B1 Condensed camptothecins as antitumor agents |
| 06/11/2008 | EP1463501B1 Cis-imidazolines as mdm2 inhibitors |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1451182B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
| 06/11/2008 | EP1313713B1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/11/2008 | EP1282436B1 Treatment of acute coronary syndrome with glp-1 |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | CN101198869A Agent for preventing and treating pancreatitis |
| 06/11/2008 | CN101198590A Novel pyridine derivative and pyrimidine derivative (3) |
| 06/11/2008 | CN101198355A Agent for prevention or treatment of glaucoma |
| 06/11/2008 | CN101198354A Preventive or remedy for glaucoma |
| 06/11/2008 | CN101198341A Antipyrotic |